Parveen Akhtar

Parveen Akhtar

Auto-generated profile, based on publicly available information

Parveen Akhtar

National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2025 in Pakistan Heart Journal
Verified
Journal Article
Open access
PDF file
TETaymmia Ejaz
Taymmia Ejaz
PAParveen Akhtar
Parveen Akhtar
ASAisha Fareed Siddiqui
Aisha Fareed Siddiqui
HKHina Khilji
Hina Khilji
RKRameesha Khalid
Rameesha Khalid
MIMuhammad Irfan
Muhammad Irfan
Objectives: Pulmonary embolism (PE) is a major contributor to cardiovascular-related morbidity and mortality worldwide. While right ventricular dysfunction (RVD) is a well-established prognostic marker, the impact of left ventricular dysfunction (LVD) in PE remains less clearly defined. This study aimed to determine the prevalence and prognostic significance of echocardiographic dysfunction in patients with intermediate-risk (submassive) PE in a Pakistani population. Methodology: A retrospective observational study was conducted from January 2022 to September 2024 at Aga Khan University Hospital, Karachi. Patients with intermediate-risk PE were identified, and echocardiographic parameters of right and left ventricular function were assessed. Outcomes included in-hospital mortality, hemodynamic decompensation, and 30-day mortality. Results: A total of 109 patients were included (median age 60 years, IQR 42–72.5; 51.4% males). Of these, 41.3% were categorized as intermediate-high risk, and 58.7% as intermediate-low risk. Thrombolytic therapy was administered to 26 patients. Echocardiography revealed RVD in 48.6% and LVD in 13.8% of patients. LVD was associated with higher rates of decompensation (28.6% vs. 12.2%) and 30-day mortality (20% vs. 9.6%), though these differences were not statistically significant. Conversely, RVD was significantly associated with adverse outcomes, including increased in-hospital mortality (17% vs. 1.8%, p=0.006), decompensation (24.5% vs. 1.8%, p<0.001), and adverse event rates (35.8% vs. 10.7%, p=0.02). Overall, in-hospital mortality was 8.3% and 30-day mortality was 11%.No statistically significant differences were observed in patients who received thrombolytics when compared with anti-coagulation (11.2% vs 7.2% p-value 0.486). Conclusion: LVD was identified in a subset of intermediate-risk PE patients, showing a trend toward poorer short-term outcomes. RVD, however, remained a stronger and statistically significant predictor of adverse outcomes. These findings underscore the need for individualized risk stratification and incorporation of LV assessment into prognostic models for PE management in South Asian populations.

20 September 2026 in Pakistan Heart Journal
Verified
Journal Article
Open access
PDF file
KCKalsoom Chachar
Kalsoom Chachar
NKNaveed Ullah Khan
Naveed Ullah Khan
MYMuhammad Younis
Muhammad Younis
ABAhsan Baig
Ahsan Baig
FQFaisal Qadir
Faisal Qadir
PAParveen Akhter
Parveen Akhter
Objectives: This study aimed to evaluate the knowledge, perceptions, and uptake of influenza, pneumococcal, and Coronavirus Disease 2019 (COVID-19) vaccines among patients with heart failure (HF) presenting to a tertiary care cardiac center and to identify factors associated with vaccine compliance and hesitancy. Methodology: This analytical cross-sectional included patients aged above 30 years with clinically and echocardiographically confirmed HF were enrolled using consecutive sampling after obtaining informed consent. Data regarding demographics, vaccination status, vaccine-related knowledge, perceptions, and barriers to vaccination were collected using a structured questionnaire. Vaccination status was determined primarily through self-report and verified using vaccination cards where available. Results: A total of 258 participants were included in the final analysis, with a mean age of 56.3 ± 13.2 years, and 75.2% (n=194) were male. Uptake of influenza, COVID-19, and pneumococcal vaccines was observed in 23.6% (n=61), 77.1% (n=199), and 14.7% (n=38) of participants, respectively. Influenza and pneumococcal vaccination status showed significant associations with socioeconomic status and place of residence, while educational status and duration of HF were additionally associated with influenza vaccination uptake. Knowledge regarding vaccine availability, physician recommendation, and positive perceptions regarding vaccine safety demonstrated strong associations with uptake of all three vaccines (p<0.001). Major barriers to vaccination included lack of physician recommendation, unawareness regarding vaccine availability, financial constraints, and misconceptions related to vaccine safety and effectiveness. Conclusion: Vaccination uptake among patients with HF, particularly for influenza and pneumococcal vaccines, remains suboptimal despite established guideline recommendations. Limited awareness, inadequate physician counseling, socioeconomic disparities, and vaccine-related misconceptions were identified as major barriers to vaccine compliance. Targeted patient education, physician-driven counseling, and improved accessibility and affordability of vaccines may help enhance vaccination coverage in this high-risk population.

1 May 2026 in Pakistan Heart Journal
Verified
Journal Article
Open access
PAParveen Akhtar
Parveen Akhtar
KHKiran Hanif
Kiran Hanif
TRTaruba Rais
Taruba Rais
ANAbdullah Nadeem
Abdullah Nadeem
NKNaveed Ullah Khan
Naveed Ullah Khan
AHAbdul Sattar M. Hashim
Abdul Sattar M. Hashim
Objectives: This study evaluates Cardiovascular Magnetic Resonance (CMR) imaging findings in a Pakistani cohort over a three-year period, focusing on the prevalence and characteristics of non-ischemic versus ischemic heart disease, gender-based differences in cardiovascular pathology, and the association between late gadolinium enhancement (LGE), left ventricular (LV) size, and systolic function. Methodology: A prospective analysis was conducted on CMR data from 306 participants, with a mean age of 41.62 years. Descriptive statistics summarized patient demographics and imaging characteristics, including ventricular size, thrombus location, infarct distribution, systolic function, presence of hyperenhancement on LGE, atrial septal defects (ASDs), and pericardial involvement. Chi-square tests and correlation analyses were employed to explore associations between gender, ventricular morphology, systolic function, and LGE findings. Results: The average left ventricular ejection fraction (LVEF) was 41.97%. Among participants, 82.4% had non-ischemic CMR findings, while 17.6% had ischemic involvement, suggesting that non-ischemic pathology predominated in this cohort. Significant gender differences were noted: 48.4% of males vs. 14.1% of females exhibited hyperenhancement, and 13.7% of males vs. 3.6% of females showed RV dilation. ASDs were detected in 1.0% of patients, aneurysms in 2.6%, and pericardial effusion in 6.9%. While no significant associations were found between gender and thrombus location or systolic function, strong correlations were observed between LV size, LGE hyperenhancement, and systolic performance. Conclusion: Non-ischemic cardiac pathology is prevalent in this Pakistani cohort, with marked gender-based differences in CMR findings. The correlation between ventricular size, systolic function, and LGE underscores the importance of precision imaging and tailored cardiovascular management in this population.

1 January 2026 in Pakistan Heart Journal
Verified
Journal Article
Open access
PDF file
SNShakeela Naz
Shakeela Naz
AAAneel Ahmed
Aneel Ahmed
NKNaveed Ullah Khan
Naveed Ullah Khan
SGSumyia Gurmani
Sumyia Gurmani
KZKiran Zahra
Kiran Zahra
PAParveen Akhtar
Parveen Akhtar
Objectives: The presence of thrombus in the left atrium (LA) or left atrial appendage (LAA) is a frequent contraindication for percutaneous mitral balloon valvotomy (PMBV). However, previous studies have indicated that PMBV may be feasible in selected thrombus types without increasing the risk of thromboembolic complications. This study aimed to classify LA/LAA thrombi based on their location and extension. Methodology: This study included 100 patients with rheumatic mitral stenosis (MS) and documented thrombus in the LA or LAA. All patients underwent transthoracic echocardiography (TTE), followed by transesophageal echocardiography (TEE) in cases where TTE did not reveal thrombus. Thrombi were categorized into seven types as described in previous literature: type Ia (confined to appendage), Ib (protruding into LA cavity), IIa (above the plane of fossa ovalis), IIb (below the plane of fossa ovalis), III (over the interatrial septum), IV (mobile clot attached to the LA free wall, roof, or interatrial septum), and V (free floating). Results: Of the 100 patients, 70% were female, with a mean age of 46.1 ± 12.2 years. Atrial fibrillation was present in 84% of cases. Thrombus was detected on TTE in 15% of patients, while 85% were diagnosed via TEE. The most common thrombus type was Ia (69%), followed by type Ib (21%), both of which are considered suitable for PMBV. The "chicken wing" morphology was the most prevalent LAA shape (46%), followed by the "windsock" (26%) and "cactus" (6%) shapes. Conclusion: Thrombus types Ia, Ib, and IIa were the most frequently observed and are considered feasible for PMBV. The chicken wing morphology was the most common LAA shape in this cohort. These findings may support the potential role of PMBV in selected patients with LA/LAA thrombi.

30 June 2026 in Pakistan Heart Journal
Verified
Journal Article
Open access
PBPoonam Bai
Poonam Bai
MZMishal Zehra
Mishal Zehra
SSSufyan Shahid
Sufyan Shahid
KBKomal Bai
Komal Bai
PKPashmina Kumari
Pashmina Kumari
PAParveen Akhtar
Parveen Akhtar
Objective: This study aimed to determine the prevalence of significant left main (LM) and proximal left anterior descending (pLAD) coronary artery disease and to identify factors associated with their presence in patients presenting with acute inferior wall myocardial infarction (IWMI). Methodology: A prospective observational cross-sectional study was conducted at a tertiary care cardiac center between February and August 2022. Ninety-six consecutive adult patients presenting with acute IWMI underwent coronary angiography and were included in the analysis. Significant coronary artery disease was defined as ≥50% stenosis in the LM coronary artery and ≥70% stenosis in the pLAD artery. Results: A total of 96 patients were enrolled, including 63 males (65.6%) and 33 females (34.4%), with a mean age of 57.8 ± 10.4 years. Isolated LM disease was identified in 1 patient (1.0%), isolated pLAD disease in 44 patients (45.8%), and combined LM and pLAD involvement in 6 patients (6.3%). Overall, pLAD involvement was present in 52.1% of patients, while LM involvement was observed in 7.3%. Hypertension (52.1%) and diabetes mellitus (37.5%) were the most prevalent cardiovascular risk factors. Multivariable logistic regression demonstrated that hypertension (adjusted OR = 1.96, 95% CI: 1.10–3.50; p = 0.01), diabetes mellitus (adjusted OR = 2.67, 95% CI: 1.30–5.51; p = 0.001), and family history of coronary artery disease (adjusted OR = 3.09, 95% CI: 1.43–6.82; p < 0.001) were independently associated with the presence of LM and/or pLAD disease. Conclusion: Significant proximal LAD involvement was common among patients presenting with acute IWMI, whereas left main coronary artery disease occurred less frequently. Traditional cardiovascular risk factors, particularly hypertension, diabetes mellitus, and family history of coronary artery disease, were independently associated with the presence of LM and/or pLAD disease.

1 January 2019 in Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
TATariq Ashraf
Tariq Ashraf
PAParveen Akhter
Parveen Akhter
AAAbdul Samad Achakzai
Abdul Samad Achakzai
NKNaveedullah Khan
Naveedullah Khan
TSTahir Saghir
Tahir Saghir
KAKanwal Fatima Aamir
Kanwal Fatima Aamir